Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 49 Letrozole 42 Fulvestrant 42 Paclitaxel 38 pembrolizumab 34 Magnetic Resonance Spectroscopy 31 Carboplatin 31 ribociclib 26 Trastuzumab 26 Biopsy 26 exemestane 23 Anastrozole 23 Capecitabine 22 palbociclib 21 pertuzumab 20 Tamoxifen 19 trastuzumab deruxtecan 18 abemaciclib 18 Cyclophosphamide 17 Taxes 15 Radiotherapy 14 130-nm albumin-bound paclitaxel 12 elacestrant 11 Docetaxel 11 sacituzumab govitecan 9 olaparib 9 Standard of Care 9 Radiation 9 Goserelin 9 Gemcitabine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

EC regimen × Breast × 30 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡